Novo Nordisk Q3 Profit Beats Forecasts
Wegovy maker Novo Nordisk reported third quarter adjusted operating profit above expectations and raised its full year profit and sales outlook on Wednesday.
Xurve View
洞察:
Xurve View
NOVO NORDISK A/S-B posted third-quarter adjusted operating profit above expectations on Wednesday morning and raised its full-year guidance. The pharmaceutical giant benefited from robust demand for its Wegovy treatment. The strong performance underscores the firm's dominant position in the global weight-loss drug market.
